CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)

Front Oncol. 2021 Nov 5:11:730194. doi: 10.3389/fonc.2021.730194. eCollection 2021.

¹ Clinic of Hematology, Ospedali Riuniti, Ancona, Italy.
² Department of Traslational and Precision Medicine, Sapienza University, Roma, Italy.
³ Hematology, Department of Translational Medicine, University of Eastern Piedmont and AOU Maggiore della Carità, Novara, Italy.
⁴ Division of Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy.
⁵ Department of Hematology and Cell Therapy, San Bortolo Hospital, Vicenza, Italy.
⁶ Division of Hematology, IRCCS Ospedale Oncologico, Bari, Italy.
⁷ Department of Onco-Hematology, Hematology Unit, A.O of Cosenza, Cosenza, Italy.
⁸ Unit of Hematology and Stem Cell Transplantation, University "Campus Bio-Medico", Rome, Italy.
⁹ Division of Hematology, Ospedale Oncologico Armando Businco, Cagliari, Italy.
¹⁰ Department of Hematology, Azienda Ospedaliero Universitaria Citta`della Salute e della Scienza di Torino, Torino, Italy.
¹¹ Division of Hematology, Ospedale Niguarda Ca' Granda, Milan, Italy.
¹² San Raffaele Hospital, IRCCS, Milano, Italy.
¹³ Hematology Unit, IRCCS Humanitas Cancer Center, Milan, Italy.

No abstract available

Keywords: central nervous system involvement; diffuse large B cell lymphoma (DLBCL); prophylaxis; risk assessment; survey.